Search Results - Alfa,

Andexanet Alfa for the Reversal of Factor Xa Inhibitor-associated Intracranial Hemorrhage: A Case Series.

Authors: Aldeeb, Mohammad Saleh¹ modeeb@me.com

Source: Indian Journal of Critical Care Case Reports (IJCCR). Sep/Oct2026, Vol. 5 Issue 5, p121-124. 4p.

Natural thermo-insulation panels made from local renewable resources: esparto grass (alfa) and kenaf fibres.

Alternate Title: Panouri termoizolante naturale realizate din resurse regenerabile locale: fibre de iarbă esparto (alfa) și fibre de kenaf.

Authors: MLIK, YOSR BEN ZOUARI, RIADH JAOUADI, MOUNIR et al.

Source: Industria Textila. 2026, Vol. 77 Issue 4, p594-599. 6p.

An analysis of cost-saving in the German statutory health insurance system due to the introduction of epoetin alfa biosimilars in Germany.

Authors: Raitner I Müller B Vijayan A et al.

Source: Frontiers in public health [Front Public Health] 2025 Dec 16; Vol. 13, pp. 1667315. Date of Electronic Publication: 2025 Dec 16 (Print Publication: 2025).

Publication Type: Journal Article

Journal Info: Publisher: Frontiers Editorial Office Country of Publication: Switzerland NLM ID: 101616579 Publication Model: eCollection Cited Medium: Internet ISSN: 2296-2565 (Electronic) Linking ISSN: 22962565 NLM ISO Abbreviation: Front Public Health Subsets: MEDLINE

Darbepoetin alfa for the treatment of anemia in myelodysplastic syndromes: a post-marketing surveillance study in Japan.

Authors: Morita Y Tsuji Y Yasukawa T et al.

Source: International journal of hematology [Int J Hematol] 2026 Oct; Vol. 124 (4), pp. 502-520. Date of Electronic Publication: 2026 May 18.

Publication Type: Journal Article

Journal Info: Publisher: Springer Japan Country of Publication: Japan NLM ID: 9111627 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1865-3774 (Electronic) Linking ISSN: 09255710 NLM ISO Abbreviation: Int J Hematol Subsets: MEDLINE

Comparative efficacy of epoetin alfa vs. darbepoetin in children with chronic kidney disease: a systematic review, meta-analysis and cost-effectiveness analysis.

Authors: Bertazza Partigiani N D'Uva A Vigezzi S et al.

Source: Journal of nephrology [J Nephrol] 2025 Nov; Vol. 38 (8), pp. 2095-2109. Date of Electronic Publication: 2025 May 11.

Publication Type: Comparative Study; Journal Article; Meta-Analysis; Systematic Review

Journal Info: Publisher: Springer Country of Publication: Italy NLM ID: 9012268 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1724-6059 (Electronic) Linking ISSN: 11218428 NLM ISO Abbreviation: J Nephrol Subsets: MEDLINE

Potential Association Between Darbepoetin Alfa Administration and Reduced Proteinuria in Real-World Clinical Practice: A Post Hoc Analysis of the BRIGHTEN Study.

Authors: Hirashio S Masaki T Kagimura T et al.

Source: Nephrology (Carlton, Vic.) [Nephrology (Carlton)] 2025 Oct; Vol. 30 (10), pp. e70140.

Publication Type: Journal Article; Observational Study

Journal Info: Publisher: Blackwell Science Country of Publication: Australia NLM ID: 9615568 Publication Model: Print Cited Medium: Internet ISSN: 1440-1797 (Electronic) Linking ISSN: 13205358 NLM ISO Abbreviation: Nephrology (Carlton) Subsets: MEDLINE

MarketLine Company Profile: Alfa Laval AB.

Source: Alfa Laval AB MarketLine Company Profile. 5/14/2026, p1-38. 38p.

Long-Term Transfusion Independence with Luspatercept Versus Epoetin Alfa in Erythropoiesis-Stimulating Agent-Naive, Lower-Risk Myelodysplastic Syndromes in the COMMANDS Trial.

Authors: Garcia-Manero G Santini V Zeidan AM et al.

Source: Advances in therapy [Adv Ther] 2025 Jul; Vol. 42 (7), pp. 3576-3589. Date of Electronic Publication: 2025 May 16.

Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Multicenter Study; Comparative Study

Journal Info: Publisher: Health Communications Inc Country of Publication: United States NLM ID: 8611864 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1865-8652 (Electronic) Linking ISSN: 0741238X NLM ISO Abbreviation: Adv Ther Subsets: MEDLINE

The Selection of Andexanet Alfa vs. 4‐Factor Prothrombin Complex Concentrate for the Treatment of Life‐Threatening Hemorrhage.

Authors: Galeano, Kira Culbreth, Rachel E. Brent, Jeffrey et al.

Source: Journal of Clinical Pharmacy & Therapeutics. 9/21/2026, Vol. 2026, p1-13. 13p.

Characterization of Synergistic Enhancement of Compressed Earth Blocks Through Alfa Fiber and Binder Incorporation.

Authors: Bouteldja, Ines Grine, Khaled Kenai, Said et al.

Source: Buildings (2075-5309); Jun2026, Vol. 16 Issue 12, p2344, 22p

硫培非格司亭与艾贝格司亭α注射液对肿瘤化疗后中性 粒细胞减少症的治疗效果评价.

Alternate Title: Evaluation of the therapeutic effect of mecapegfilgrastim and efbemalenograstim alfa injection in the treatment of chemotherapy-induced neutropenia.

Authors: 徐丹 刘倩 汪丽钰 et al.

Source: Tianjin Medical Journal. Oct2026, Vol. 54 Issue 10, p1099-1103. 5p.

A Simple Rapid HPLC-UV Method for Assessing C-Terminal Arginine Content in Darbepoetin Alfa.

Authors: Zybin DI Klishin AA Orlova NV et al.

Source: Biomedical chromatography : BMC [Biomed Chromatogr] 2025 Mar; Vol. 39 (3), pp. e70018.

Publication Type: Journal Article

Journal Info: Publisher: Wiley Country of Publication: England NLM ID: 8610241 Publication Model: Print Cited Medium: Internet ISSN: 1099-0801 (Electronic) Linking ISSN: 02693879 NLM ISO Abbreviation: Biomed Chromatogr Subsets: MEDLINE

Clinical and Biochemical Improvement After Switching From Agalsidase Alfa to Beta in a Boy With Classic Fabry Disease: A Case Report.

Authors: Koga, Nobuhiko Yodogawa, Hiroaki Sawada, Takaaki et al.

Source: Clinical Case Reports. Aug2026, Vol. 14 Issue 8, p1-5. 5p.

Short-Term Intensive Avalglucosidase Alfa Regimen in Late-Diagnosed Infantile Pompe Disease: A Case Report.

Authors: Gragnaniello, Vincenza Pozza, Alice Cazzorla, Chiara et al.

Source: Reports (MDPI AG). Mar2026, Vol. 9 Issue 1, p31. 10p.

ALFA DT: a digital twin for assembly line fitness analytics.

Authors: Makke, Omar Gusikhin, Oleg Hashemi-Petroodi, S. Ehsan et al.

Source: International Journal of Production Research. Jun2026, p1-24. 24p. 14 Illustrations.

Pompe infantil tratado con alglucosidasa alfa e inmunomodulación.

Alternate Title: Infantile-onset Pompe disease treated with alglucosidase alfa and immunomodulation.

Authors: Cristina Sesman-Bernal, Brenda Gabriela Jiménez-Martínez, Cielo María Sánchez-Sánchez, Luz et al.

Source: Revista Mexicana de Pediatria. nov/dic2025, Vol. 92 Issue 6, p237-240. 4p.

Subjects: Enzyme replacement therapy, Immunological tolerance, Immunoregulation, Respiratory diseases, Cardiomyopathies, Alpha-glucosidases, Glycogen storage disease type II

Sosyal Medyanın Gölgesinde Büyümek: Alfa Kuşağında Mahremiyet Algısı.

Alternate Title: Growing Up in the Shadow of Social Media: Perceptions of Privacy Among Generation Alpha.

Authors: MEHMETBEYOĞLU, Nuri¹ nuri.mehmetbeyoglu@icisleri.gov.tr

Source: Alinteri Journal of Social Sciences. 2026, Vol. 10 Issue 2, p176-189. 14p.

Assessing EPO stability in urine and comparing recombinant EPO detectability in matched urine, venous serum, and capillary serum following a controlled epoetin alfa administration.

Authors: Miller GD Goodrum JM Crouch AK et al.

Source: Drug testing and analysis [Drug Test Anal] 2025 Mar; Vol. 17 (3), pp. 358-364. Date of Electronic Publication: 2024 May 24.

Publication Type: Journal Article; Comparative Study

Journal Info: Publisher: John Wiley & Sons Country of Publication: England NLM ID: 101483449 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1942-7611 (Electronic) Linking ISSN: 19427603 NLM ISO Abbreviation: Drug Test Anal Subsets: MEDLINE

Effectiveness of Octocog Alfa (BAY 81‐8973) to Treat People With Haemophilia A Enrolled in the ATHNdataset, Including Under‐Represented Subgroups.

Authors: Chandler, Martin Moulton, Thomas Charafi, Lena et al.

Source: European Journal of Haematology. Nov2025, Vol. 115 Issue 5, p484-492. 9p.

Epoetin alfa has a potent anxiolytic effect on naive female rats.

Authors: Çalışkan H Koçak S Güneş E

Source: BMC pharmacology & toxicology [BMC Pharmacol Toxicol] 2025 Jan 28; Vol. 26 (1), pp. 18. Date of Electronic Publication: 2025 Jan 28.

Publication Type: Journal Article

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101590449 Publication Model: Electronic Cited Medium: Internet ISSN: 2050-6511 (Electronic) Linking ISSN: 20506511 NLM ISO Abbreviation: BMC Pharmacol Toxicol Subsets: MEDLINE